Literature DB >> 25878200

Intrauterine Morcellator Devices: The Icon of Hysteroscopic Future or Merely a Marketing Image? A Systematic Review Regarding Safety, Efficacy, Advantages, and Contraindications.

Marco Noventa1, Emanuele Ancona1, Michela Quaranta2, Amerigo Vitagliano2, Erich Cosmi1, Donato D'Antona1, Salvatore Gizzo3.   

Abstract

The aim of this study was to analyze all available evidence regarding the use of intrauterine morcellator (IUM), for treatment of the most prevalent intrauterine benign lesions, compared to both traditional resectoscopy and conventional outpatient operative hysteroscopy in terms of safety, efficacy, contraindications, perioperative complications, operating time, and estimated learning curve. We reported data regarding a total of 1185 patients. Concerning polypectomy and myomectomy procedures, IUM systems demonstrated a better outcome in terms of operative time and fluid deficit compared to standard surgical procedures. Complication rates in the inpatient setting were as follows: 0.02% for IUM using Truclear 8.0 (Smith & Nephew Endoscopy, Andover, Massachusetts) and 0.4% for resectoscopic hysteroscopy. No complications were described using Versapoint devices. Office polipectomy reported a total complication rate of 10.1% using Versapoint device (Ethicon Women's Health and Urology, Somerville, New Jersey) and 1.6% using Truclear 5.0 (Smith & Nephew Endoscopy). The reported recurrence rate after polypectomy was 9.8% using Versapoint device and 2.6% using Truclear 8.0. Finally, the reported intraoperative and postoperative complication rate of IUM related to removal of placental remnants using Truclear 8.0 and MyoSure (Hologic, Marlborough, Massachusetts) was 12.3%. The available evidence allows us to consider IUM devices as a safe, effective, and cost-effective tool for the removal of intrauterine lesions such as polyps, myomas (type 0 and type 1), and placental remnants. Evidence regarding Truclear 5.0 suggests that it may represent the best choice for office hysteroscopy. Further studies are needed to confirm the available evidence and to validate the long-term safety of IUM in procedures for which current data are not exhaustive (placental remnants removal).
© The Author(s) 2015.

Entities:  

Keywords:  endometrial polyps; intrauterine morcellator; learning curve; office hysteroscopy; placental remnants; submucous uterine myomas

Mesh:

Year:  2015        PMID: 25878200     DOI: 10.1177/1933719115578929

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  7 in total

1.  Sonographic assessment of placental location: a mere notional description or an important key to improve both pregnancy and perinatal obstetrical care? A large cohort study.

Authors:  Salvatore Gizzo; Marco Noventa; Amerigo Vitagliano; Michela Quaranta; Valentina Di Giovanni; Shara Borgato; Carlo Saccardi; Donato D'Antona
Journal:  Int J Clin Exp Med       Date:  2015-08-15

2.  The Impact of Hysteroscopic Tissue Removal Systems on Histopathologic Analysis for Benign and Cancerous Endometrial Pathology: An Ex Vivo Study.

Authors:  Steven R Lindheim; Kimberly Lincenberg; Michelle A Wood; Emily Kemner; Megan K Burns; Daniel L Hood; Rose Maxwell; Miryoung Lee
Journal:  J Obstet Gynaecol India       Date:  2018-09-11

Review 3.  Hysteroscopic Morcellation of Submucous Myomas: A Systematic Review.

Authors:  Salvatore Giovanni Vitale; Fabrizio Sapia; Agnese Maria Chiara Rapisarda; Gaetano Valenti; Fabrizia Santangelo; Diego Rossetti; Benito Chiofalo; Giuseppe Sarpietro; Valentina Lucia La Rosa; Onofrio Triolo; Marco Noventa; Salvatore Gizzo; Antonio Simone Laganà
Journal:  Biomed Res Int       Date:  2017-08-29       Impact factor: 3.411

4.  Hysteroscopic myomectomy without anesthesia.

Authors:  Nuria-Laia Rodríguez-Mias; Montserrat Cubo-Abert; Laura Gomila-Villalonga; Juanjo Gómez-Cabeza; Jose Luis Poza-Barrasús; Antonio Gil-Moreno
Journal:  Obstet Gynecol Sci       Date:  2019-04-04

5.  Endometrial Cancer Risk Prediction According to Indication of Diagnostic Hysteroscopy in Post-Menopausal Women.

Authors:  Carlo Saccardi; Amerigo Vitagliano; Matteo Marchetti; Alice Lo Turco; Sofia Tosatto; Michela Palumbo; Luciana Serena De Lorenzo; Salvatore Giovanni Vitale; Marco Scioscia; Marco Noventa
Journal:  Diagnostics (Basel)       Date:  2020-04-27

6.  Mechanical hysteroscopic tissue removal or hysteroscopic morcellator: understanding the past to predict the future. A narrative review.

Authors:  M Franchini; O Ceci; P Casadio; J Carugno; G Giarrè; G Gubbini; U Catena; M Chiara de Angelis; A Di Spiezio Sardo
Journal:  Facts Views Vis Obgyn       Date:  2021-06-10

7.  Comparison of Hysteroscopic Morcellation Versus Resectoscopy in Treatment of Patients with Endometrial Lesions: A Meta-Analysis.

Authors:  Fangying Ren; Guannan Huang; Xue Wang; Xuehui Li; Jianning Cai
Journal:  Med Sci Monit       Date:  2022-07-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.